A detailed history of C World Wide Group Holding A transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, C World Wide Group Holding A holds 1,928,464 shares of CHRS stock, worth $2.12 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,928,464
Previous 1,928,464 -0.0%
Holding current value
$2.12 Million
Previous $3.34 Million 39.87%
% of portfolio
0.02%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023

BUY
$3.79 - $8.3 $3.79 Million - $8.3 Million
1,000,000 Added 107.7%
1,928,464 $8.24 Million
Q3 2021

Nov 01, 2021

SELL
$12.68 - $17.79 $1.65 Million - $2.31 Million
-130,000 Reduced 12.28%
928,464 $14.9 Million
Q3 2020

Nov 02, 2020

BUY
$17.41 - $19.89 $2.61 Million - $2.98 Million
150,000 Added 16.51%
1,058,464 $19.4 Million
Q1 2020

May 04, 2020

BUY
$11.67 - $22.53 $1.17 Million - $2.25 Million
100,000 Added 12.37%
908,464 $14.7 Million
Q3 2019

Nov 04, 2019

BUY
$16.3 - $23.37 $2.12 Million - $3.04 Million
130,000 Added 19.16%
808,464 $16.4 Million
Q2 2019

Aug 02, 2019

BUY
$13.1 - $22.1 $6.29 Million - $10.6 Million
480,000 Added 241.86%
678,464 $15 Million
Q1 2019

May 03, 2019

BUY
$8.38 - $15.5 $234,128 - $433,054
27,939 Added 16.38%
198,464 $2.71 Million
Q4 2018

Feb 12, 2019

SELL
$8.65 - $16.28 $496,259 - $933,999
-57,371 Reduced 25.17%
170,525 $1.54 Million
Q3 2018

Nov 05, 2018

SELL
$14.45 - $20.25 $567,321 - $795,035
-39,261 Reduced 14.7%
227,896 $3.76 Million
Q2 2018

Aug 03, 2018

BUY
$10.25 - $17.45 $962,905 - $1.64 Million
93,942 Added 54.23%
267,157 $3.74 Million
Q1 2018

May 03, 2018

SELL
$9.1 - $13.7 $242,414 - $364,954
-26,639 Reduced 13.33%
173,215 $1.91 Million
Q4 2017

Feb 07, 2018

SELL
$8.35 - $14.4 $326,626 - $563,284
-39,117 Reduced 16.37%
199,854 $1.76 Million
Q3 2017

Nov 06, 2017

BUY
$11.1 - $14.5 $2.65 Million - $3.47 Million
238,971
238,971 $3.19 Million

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $85.5M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track C World Wide Group Holding A Portfolio

Follow C World Wide Group Holding A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

News

Stay updated on C World Wide Group Holding A with notifications on news.